1. Nebuliser performance, pharmacokinetics, airways and systemic effects of salbutamol given via a novel nebuliser system (Ventstream);Newnham, D.M.; Lipworth, B.J.;Thorax,1994
2. Wastage of drug from nebulisers: a review;Clay, M.M.; Clarke, S.W.;J R Soc Med,1987
3. Efficiency of air compressor driven nebulisers;Kradjan, W.A.; Lakshminarayan, S.;Chest,1985
4. Comparison of bronchodilator responses and deposition patterns of salbutamol inhaled from a pressurised metered dose inhaler, as a dry powder, and as a nebulised solution;Zainudin, B.M.Z.; Biddiscombe, M.; Tolfree, S.E.J.; Short, M.; Spiro, S.G.;Thorax,1990
5. Dornase alpha: a review of its pharmacological properties and therapeutic potential in cystic fibrosis;Bryson, H.M.; Sorkin, E.M.;Drugs,1994